Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma
Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma have?
Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma has 366 citations in the OpenAlex counts ScholarIQ stores.
When was Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma published?
Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma has 2018 year in the ScholarIQ index.
What is the open-access status of Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma?
Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma has bronze oa status in the ScholarIQ index.
What is the DOI of Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma?
The DOI for Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma is on the source record.
What is the PMID of Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma?
The PMID for Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma is on the source record.
What is the OpenAlex record for Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma?
The OpenAlex for Rituximab plus Lenalidomide in Advanced Untreated Follicular Lymphoma is on the source record.